SCHEMBL30699478

SCHEMBL30699478

Fc1cc(F)c2nc(Cl)nc(Cl)c2c1OCc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM1A O60341 5/20 0.40
▸ MAOA P21397 2/20 0.40
▸ MAOB P27338 2/20 0.40
▸ ALOX5AP P20292 1/20 0.38
▸ FEN1 P39748 1/20 0.38
▸ ALOX5 P09917 1/20 0.36
▸ PIN1 Q13526 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ THRA P10827 1/20 0.35
▸ THRB P10828 1/20 0.35
▸ HTR1A P08908 1/20 0.34
▸ SLC6A2 P23975 1/20 0.34
▸ SLC6A4 P31645 1/20 0.34
▸ SLC6A3 Q01959 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30699675 0.76 KDM1A (0.40) KDM1AMAOAMAOBALOX5THRA
SCHEMBL30699627 0.75 APP (0.31) —
SCHEMBL30989561 0.74 SMN1; SMN2 (0.38) KDM1AMAOBALOX5SMN1; SMN2THRA
SCHEMBL25359554 0.70 KDM1A (0.49) KDM1AMAOAMAOBALOX5APFEN1
SCHEMBL30699586 0.69 — —
SCHEMBL30259750 0.69 KDM1A (0.56) KDM1AMAOAMAOBALOX5APFEN1
SCHEMBL11217127 0.68 ALOX5AP (0.45) KDM1AMAOAMAOBALOX5APFEN1
SCHEMBL9823890 0.68 KDM1A (0.50) KDM1AMAOAMAOBTHRATHRB
SCHEMBL3410935 0.68 KDM1A (0.45) KDM1AMAOAMAOBALOX5APFEN1
SCHEMBL25165363 0.67 PIN1 (0.40) MAOBALOX5APFEN1PIN1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023244713-A1 QUINAZOLINE DERIVATIVES, COMPOSITIONS AND METHODS THEREOF ENSEM THERAPEUTICS, INC. (US) 2023-12-21 — — WO disclosed
Send feedback